Skip to main content
OpenTrials

Clinical trial condition

Primary Myelofibrosis

Explore clinical trials studying Primary Myelofibrosis. Study availability and eligibility vary by location and protocol.

453 public trials 89 recruiting studies
Refine in advanced search Browse all conditions

Primary Myelofibrosis trial results

Completed

Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

NCT02396134

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, +46 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Completed

Combined Ruxolitinib and Enasidenib in Patients With Accelerated/Blast-phase Myeloproliferative Neoplasm or Chronic-phase Myelofibrosis With an IDH2 Mutation

NCT04281498

Conditions
Accelerated/Blast-phase Myeloproliferative Neoplasm, Bone Marrow Diseases, Chronic-phase Myelofibrosis, +5 more
Locations
  • Mayo Clinic - Arizona Scottsdale, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Kansas Cancer Center Westwood, Kansas, United States
View Trial Details
Completed

Tagraxofusp (SL-401) in Participants With Chronic Myelomonocytic Leukemia (CMML) and Myelofibrosis (MF)

NCT02268253

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +14 more
Locations
  • University of California, San Francisco Clovis, California, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Stanford Cancer Institute Stanford, California, United States
View all 24 locations
View Trial Details
Completed

Actuate 1901: 9-ING-41 in Myelofibrosis

NCT04218071

Conditions
Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • University of Southern California Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Georgia Cancer Center Augusta, Georgia, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details

Related conditions